AMARIN CORP PLC\UK SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
AMARIN CORP PLC\UK (AMRN) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $426.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2026-07-29
- AMARIN CORP PLC\UK sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2026-06-30 was $209.11M, a 22.08% increase year-over-year.
- AMARIN CORP PLC\UK sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2026-03-31 was $217.21M, a 16.77% increase year-over-year.
- AMARIN CORP PLC\UK sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2025-12-31 was $220.49M, a 19.20% increase year-over-year.
- AMARIN CORP PLC\UK sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2025-09-30 was $214.23M, a 8.14% increase year-over-year.
- AMARIN CORP PLC\UK sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2025 was $792.02M, a 6.43% decline from fiscal 2024.
- AMARIN CORP PLC\UK sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2024 was $846.45M, a 1.29% increase from fiscal 2023.
- AMARIN CORP PLC\UK sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2023 was $835.68M, a 4.19% increase from fiscal 2022.
- AMARIN CORP PLC\UK sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2022 was $802.12M, a 5.90% decline from fiscal 2021.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 3 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 3 month as first filed | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 6 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 9 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $209.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $426.32M 10-Q · filed 2026-07-29 | $646.81M derived: sum of 3 quarters · filed 2026-07-29 | $861.04M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2026-03-31 | $217.21M 10-Q · filed 2026-04-29 | $437.69M derived: sum of 2 quarters · filed 2026-04-29 | $651.92M derived: sum of 3 quarters · filed 2026-04-29 | $823.22M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-12-31 | $220.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $434.71M derived: sum of 2 quarters · filed 2026-03-02 | $606.01M derived: sum of 3 quarters · filed 2026-07-29 | $792.02M 10-K · filed 2026-03-02 | |
| 2025-09-30 | $214.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $385.53M derived: sum of 2 quarters · filed 2026-07-29 | $571.53M 10-Q · filed 2025-10-29 | $756.51M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-06-30 | $171.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $357.31M 10-Q · filed 2026-07-29 | $542.28M derived: sum of 3 quarters · filed 2026-07-29 | $740.40M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-03-31 | $186.01M 10-Q · filed 2026-04-29 | $370.99M derived: sum of 2 quarters · filed 2026-04-29 | $569.10M derived: sum of 3 quarters · filed 2026-04-29 | $841.75M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2024-12-31 | $184.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $383.09M derived: sum of 2 quarters · filed 2026-03-02 | $655.74M derived: sum of 3 quarters · filed 2026-03-02 | $846.45M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $198.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $470.76M derived: sum of 2 quarters · filed 2025-10-29 | $661.47M 10-Q · filed 2025-10-29 | $883.45M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-06-30 | $272.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $463.36M 10-Q · filed 2025-07-30 | $685.34M derived: sum of 3 quarters · filed 2026-03-02 | $907.45M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-03-31 | $190.71M 10-Q · filed 2025-05-07 | $235.89M 10-Q · filed 2024-05-01 | $412.69M derived: sum of 2 quarters · filed 2026-03-02 | $634.80M derived: sum of 3 quarters · filed 2026-03-02 | $835.68M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $221.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $444.09M derived: sum of 2 quarters · filed 2026-03-02 | $644.97M derived: sum of 3 quarters · filed 2026-03-02 | $835.68M 10-K · filed 2026-03-02 | |
| 2023-09-30 | $222.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $422.99M derived: sum of 2 quarters · filed 2024-10-30 | $613.70M 10-Q · filed 2024-10-30 | $830.87M derived: sum of 4 quarters · filed 2024-10-30 | |
| 2023-06-30 | $200.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $391.59M 10-Q · filed 2024-07-31 | $608.76M derived: sum of 3 quarters · filed 2024-07-31 | $795.46M derived: sum of 4 quarters · filed 2024-07-31 | |
| 2023-03-31 | $190.71M 10-Q · filed 2024-05-01 | $407.88M derived: sum of 2 quarters · filed 2024-05-01 | $594.58M derived: sum of 3 quarters · filed 2024-05-01 | $813.05M derived: sum of 4 quarters · filed 2024-05-01 | |
| 2022-12-31 | $217.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $403.87M derived: sum of 2 quarters · filed 2024-02-29 | $622.34M derived: sum of 3 quarters · filed 2024-02-29 | $802.12M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $186.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $405.17M derived: sum of 2 quarters · filed 2023-11-01 | $584.95M 10-Q · filed 2023-11-01 | $809.79M derived: sum of 4 quarters · filed 2023-11-01 | |
| 2022-06-30 | $218.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $398.25M 10-Q · filed 2023-08-02 | $623.10M derived: sum of 3 quarters · filed 2023-08-02 | $840.90M derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-03-31 | $179.77M 10-Q · filed 2023-05-03 | $404.62M derived: sum of 2 quarters · filed 2023-05-03 | $622.43M derived: sum of 3 quarters · filed 2023-05-03 | $840.87M derived: sum of 4 quarters · filed 2023-05-03 | |
| 2021-12-31 | $224.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $442.65M derived: sum of 2 quarters · filed 2023-03-01 | $661.10M derived: sum of 3 quarters · filed 2023-03-01 | $852.42M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $217.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $436.25M derived: sum of 2 quarters · filed 2022-10-27 | $627.57M 10-Q · filed 2022-10-27 | $865.18M derived: sum of 4 quarters · filed 2022-10-27 | |
| 2021-06-30 | $218.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $409.77M 10-Q · filed 2022-08-03 | $647.37M derived: sum of 3 quarters · filed 2022-08-03 | $870.60M derived: sum of 4 quarters · filed 2022-08-03 | |
| 2021-03-31 | $191.32M 10-Q · filed 2022-05-04 | $428.93M derived: sum of 2 quarters · filed 2022-05-04 | $652.15M derived: sum of 3 quarters · filed 2022-05-04 | $830.43M derived: sum of 4 quarters · filed 2022-05-04 | |
| 2020-12-31 | $237.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $460.83M derived: sum of 2 quarters · filed 2022-03-01 | $639.11M derived: sum of 3 quarters · filed 2022-03-01 | $822.81M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $223.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $401.50M derived: sum of 2 quarters · filed 2021-11-03 | $585.21M 10-Q · filed 2021-11-03 | $761.91M derived: sum of 4 quarters · filed 2021-11-03 | |
| 2020-06-30 | $178.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $361.98M 10-Q · filed 2021-08-05 | $538.69M derived: sum of 3 quarters · filed 2021-08-05 | $685.80M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $183.70M 10-Q · filed 2021-04-29 | $360.41M derived: sum of 2 quarters · filed 2021-04-29 | $507.52M derived: sum of 3 quarters · filed 2021-04-29 | $634.55M derived: sum of 4 quarters · filed 2021-04-29 | |
| 2019-12-31 | $176.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $323.81M derived: sum of 2 quarters · filed 2021-02-25 | $450.85M derived: sum of 3 quarters · filed 2021-02-25 | $545.84M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $147.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $274.14M derived: sum of 2 quarters · filed 2020-11-05 | $369.13M 10-Q · filed 2020-11-05 | $452.24M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $127.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $222.03M 10-Q · filed 2020-08-04 | $305.13M derived: sum of 3 quarters · filed 2020-08-04 | $373.45M derived: sum of 4 quarters · filed 2020-08-04 | |
| 2019-03-31 | $95.00M 10-Q · filed 2020-04-30 | $178.10M derived: sum of 2 quarters · filed 2020-04-30 | $246.42M derived: sum of 3 quarters · filed 2020-04-30 | $307.41M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2018-12-31 | $83.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $151.42M derived: sum of 2 quarters · filed 2020-02-25 | $212.41M derived: sum of 3 quarters · filed 2020-02-25 | $258.27M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $68.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $129.31M derived: sum of 2 quarters · filed 2019-11-05 | $175.17M 10-Q · filed 2019-11-05 | $229.13M derived: sum of 4 quarters · filed 2019-11-05 | |
| 2018-06-30 | $60.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $106.85M 10-Q · filed 2019-07-31 | $160.81M derived: sum of 3 quarters · filed 2019-07-31 | $208.59M derived: sum of 4 quarters · filed 2019-07-31 | |
| 2018-03-31 | $45.86M 10-Q · filed 2019-05-01 | $99.82M derived: sum of 2 quarters · filed 2019-05-01 | $147.60M derived: sum of 3 quarters · filed 2019-05-01 | $193.97M derived: sum of 4 quarters · filed 2019-05-01 | |
| 2017-12-31 | $53.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $101.74M derived: sum of 2 quarters · filed 2019-02-27 | $148.10M derived: sum of 3 quarters · filed 2019-02-27 | $178.53M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $47.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $94.14M derived: sum of 2 quarters · filed 2018-11-01 | $124.57M 10-Q · filed 2018-11-01 | $157.85M derived: sum of 4 quarters · filed 2018-11-01 | |
| 2017-06-30 | $46.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $76.79M 10-Q · filed 2018-08-01 | $110.07M derived: sum of 3 quarters · filed 2018-08-01 | $136.53M derived: sum of 4 quarters · filed 2018-08-01 | |
| 2017-03-31 | $30.43M 10-Q · filed 2018-05-02 | $63.71M derived: sum of 2 quarters · filed 2018-05-02 | $90.16M derived: sum of 3 quarters · filed 2018-05-02 | $116.72M derived: sum of 4 quarters · filed 2018-05-02 | |
| 2016-12-31 | $33.28M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $59.74M derived: sum of 2 quarters · filed 2018-02-27 | $86.29M derived: sum of 3 quarters · filed 2018-02-27 | $104.60M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $26.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $53.01M derived: sum of 2 quarters · filed 2017-11-01 | $71.32M 10-Q · filed 2017-11-01 | $89.60M derived: sum of 4 quarters · filed 2017-11-01 | |
| 2016-06-30 | $26.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $44.86M 10-Q · filed 2017-08-02 | $63.15M derived: sum of 3 quarters · filed 2017-08-02 | $79.13M derived: sum of 4 quarters · filed 2017-08-02 | |
| 2016-03-31 | $18.31M 10-Q · filed 2017-05-03 | $36.59M derived: sum of 2 quarters · filed 2017-05-03 | $52.57M derived: sum of 3 quarters · filed 2017-05-03 | $64.79M derived: sum of 4 quarters · filed 2017-05-03 | |
| 2015-12-31 | $18.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $34.26M derived: sum of 2 quarters · filed 2017-03-01 | $46.48M derived: sum of 3 quarters · filed 2017-03-01 | $56.23M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $15.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $28.20M derived: sum of 2 quarters · filed 2016-11-03 | $37.94M 10-Q · filed 2016-11-03 | $52.44M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-06-30 | $12.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $21.97M 10-Q · filed 2016-08-04 | $36.46M derived: sum of 3 quarters · filed 2016-08-04 | $43.71M derived: sum of 4 quarters · filed 2016-08-04 | |
| 2015-03-31 | $9.74M 10-Q · filed 2016-05-05 | $24.24M derived: sum of 2 quarters · filed 2016-05-05 | $31.48M derived: sum of 3 quarters · filed 2016-05-05 | $37.91M derived: sum of 4 quarters · filed 2016-05-05 | |
| 2014-12-31 | $14.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $21.74M derived: sum of 2 quarters · filed 2016-02-25 | $28.16M derived: sum of 3 quarters · filed 2016-02-25 | $32.46M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $7.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $13.66M derived: sum of 2 quarters · filed 2015-08-06 | $17.96M 10-Q · filed 2014-11-06 | $22.26M derived: sum of 4 quarters · filed 2015-08-06 | |
| 2014-06-30 | $6.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $10.72M 10-Q · filed 2015-08-06 | $15.02M derived: sum of 3 quarters · filed 2015-08-06 | $18.54M derived: sum of 4 quarters · filed 2015-08-06 | |
| 2014-03-31 | $4.30M 10-Q · filed 2015-05-08 | $8.60M derived: sum of 2 quarters · filed 2015-05-08 | $12.12M derived: sum of 3 quarters · filed 2015-05-08 | $13.71M derived: sum of 4 quarters · filed 2015-05-08 | |
| 2013-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $7.82M derived: sum of 2 quarters · filed 2015-03-03 | $9.41M derived: sum of 3 quarters · filed 2015-03-03 | $11.65M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $5.11M derived: sum of 2 quarters · filed 2014-11-06 | $7.35M 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $3.83M 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | $2.23M 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |